UnitedHealth Stock News

Despite a disappointing Q3 report, Elevance Health remains attractive due to its relatively favorable valuation compared to UnitedHealth Group and a total shareholder yield of roughly 3.5%. Elevance's expansion into healthcare services through Carelon and continued strength in Medicare and Medicaid markets support long-term growth, especially given the industry's demographic tailwinds. Though 2...

UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations. The company reported revenue of $100.8 billion and adjusted earnings of $7.15 per share, compared to our estimates of $99 billion and $6.95, respectively.

UnitedHealth Group's NYSE: UNH stock price pulled back following the Q3 earnings release in what can best be described as a temper tantrum. The results weren't bad, outpacing the consensus estimates and compounded by solid guidance, but the market wanted more, so it sold off.

UnitedHealth's Q3 earnings, released yesterday, revealed significant challenges, including rising healthcare costs and reduced rate increases, impacting profitability and leading to an 8% stock drop. Medicare Advantage headwinds and increased medical benefit ratios are squeezing margins, making the business less profitable than a year ago. The company has struggled with implementing value-based...

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. However, I rate it as a Buy. The company's long-term EPS growth target of 13-16% is achievable, supported by the company's strong track record. UNH's current valuation is attractive, trading at a P/E ratio that aligns with historical trends, suggesting potential for double-digit ann...

UnitedHealth Group reported increased revenue, but also noted some cyberattack challenges that ended up affecting full-year guidance.

Shares of UnitedHealth Group (UNH) tumbled Tuesday after the company lowered its full-year profit outlook to reflect the impact of a cyberattack against its Change Healthcare division in February.

UnitedHealth Group Incorporated (NYSE:UNH ) Q3 2024 Earnings Conference Call October 15, 2024 8:45 AM ET Company Participants Andrew Witty - CEO John Rex - President and CFO Tim Noel - CEO, UnitedHealthcare Medicare & Retirement Amar Desai - CEO, Optum Health Roger Connor - CEO, Optum Insight Brian Thompson - CEO, UnitedHealthcare Heather Cianfrocco - CEO, Optum Dan Kueter - CEO, UnitedHealthca...